Q2 2025 Earnings Summary
Reported on Aug 7, 2025 (After Market Close)
Pre-Earnings Price$2.79Last close (Aug 7, 2025)
Post-Earnings Price$2.42Open (Aug 8, 2025)
Price Change
$-0.37(-13.26%)
| Metric | YoY Change | Reason |
|---|---|---|
Revenue Q1 2024 | Decreased from $38,000 in Q1 2023 to $14,000 in Q1 2024 | The decline of $24,000 is linked to the sale of MSCs to a third party in both periods; however, the documents do not offer specific details underlying the $24,000 drop in revenue. |
Revenue Q1 2025 | Increased from $14,000 in Q1 2024 to $50,000 in Q1 2025, an increase of $36,000 | The rise in revenue is primarily attributed to improved sales of MSCs to third parties compared to the previous period, reflecting a shift in sales volume and market traction. |
Research analysts covering Inmune Bio.